A Double-Blind, Placebo-Controlled, Dose Escalation Study to Assess the Efficacy, Safety and Pharmacokinetics of Voclosporin in Adolescents with Lupus Nephritis,
Role: Investigator,
Aurinia Pharmaceuticals, Inc.,
(09/2024 - 09/2025)
Status: Approved
A long-term, open-label follow-up study of tofacitinib for treatment of juvenile idiopathic arthritis (JIA),
Role: Investigator,
Pfizer Pharmaceuticals,
(05/2022 - 05/2023)
Status: Completed
A phase II, randomized, double-blind, placebo-controlled, multicenter study to evaluate the efficacy, safety, and pharmacokinetics of Obinutuzumab in adolescent patients with active class III or IV Lupus Nephritis, Including an Evaluation of Open-Label Safety and PK in a Cohort of Pediatric Patients (Aged 5 to,
Role: Investigator,
Hoffmann-La Roche Inc.,
(01/2025 - 01/2026)
Status: Approved